A new study presented at SABCS 2024 demonstrates that LumiSystem, combining Lumicell Direct Visualization System and pegulicianine, can help achieve broader surgical margins during lumpectomy procedures. The technology enabled 46.5% of patients to receive additional guided excisions, potentially reducing or eliminating the need for radiation therapy in select breast cancer patients.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.